News & Events

Aerogen is attending ISICEM 2022

15th March 2022

Aerogen is attending ISICEM 2022.

We are delighted that Aerogen is attending the 41st International Symposium on Intensive Care and Emergency Medicine, in Brussels, Belgium. We are based at stand 2.07 and 2.08 from Monday 22nd to Friday 25th March 2022. The ISICEM 2022 program is set to be full of insightful and engaging discussions. In between your busy day of attending talks please feel free to stop by our stand. We look forward to meeting with all our colleagues and customers at ISICEM 2022.

Aerogen and Safety

Expert consensus states that breaking the circuit with jet nebulisers and pMDI increases the risk of airborne infections for healthcare professionals and patients 1,2. Aerogen offers a solution, we are the only closed-circuit aerosol drug delivery system 1-6. A closed circuit mitigates infectious aerosol risk reduces the risk of re-nebulising condensate and reduces the risk of lung de-recruitment 3-6.

With Aerogen it’s Easy 1,2

Aerogen is virtually silent. There is no added flow required and no interruption to therapy3. Aerogen offers one system across the patient’s respiratory journey2.

Aerogen is Effective

Aerogen delivers 10 – 15% medication to the lungs with no medication waste. Aerogen is approved for all physician prescribed medication for inhalation1.

If you want to learn more about Aerogen then stop by our stand and chat with our team. Alternatively, if you would like to arrange a meeting with one of our team in advance, please email marketing@aerogen.com.

Discover Better.

Aerogen® is the world leader in acute care aerosol drug delivery. With 20 years’ experience and 300 international patents Aerogen® technology has been used to treat 13 million patients in 75 countries.  Based on Aerogen’s vibrating mesh technology, the Aerogen® Solo has become the gold standard for respiratory patient care in hospitals from the emergency department to intensive care.

References
  1. Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir. Med. 2020; 167. doi:10.1016/j.rmed.2020.105987. 2. Fink JB, Ehrmann S, Li J, Dailey P, McKiernan P, Darquenne C et al. Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv 2020; : jamp.2020.1615.
  2. Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir. Med. 2020; 167. doi:10.1016/j.rmed.2020.105987. 2. Miller A, Epstein D. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience. J. Crit. Care. 2020; 58: 56–57. 3. Fink JB, Ehrmann S, Li J, Dailey P, McKiernan P, Darquenne C et al. Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv 2020; : jamp.2020.1615. 4. Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The 2020 GOLD Science Committee Report on COVID-19 & COPD. Am J Respir Crit Care Med 2020. doi:10.1164/rccm.202009-3533SO. 5. O’Toole C, McGrath JA, Joyce M, Bennett G, Byrne MA, MacLoughlin R. Fugitive Aerosol Therapy Emissions during Mechanical Ventilation: In Vitro Assessment of the Effect of Tidal Volume and Use of Protective Filters. Aerosol Air Qual Res 2020; 20. doi:10.4209/aaqr.2020.04.017 6. Joyce M, McGrath JA, Mac Giolla Eain M, O’Sullivan A, Byrne M, MacLoughlin R. Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation. Pharmaceutics 2021; 13: 199.
  3. Ari A. Jet, Ultrasonic, and Mesh Nebulizers: An Evaluation of Nebulizers for Better Clinical Outcomes. Eurasian J Pulmonol 2014; 16: 1–7 2. Aerogen Solo Instruction Manual, 2021. 3. Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir. Med. 2020; 167. doi:10.1016/j. rmed.2020.105987.
  4. Dugernier J, Reychler G, Wittebole X, Roeseler J, Depoortere V, Sottiaux T, Michotte JB, Vanbever R, Dugernier T, Goffette P, Docquier MA, Raftopoulos C, Hantson P, Jamar F and Laterre PF. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Annals of intensive care. 2016;6:73